E-LIB Suche - Ergebnisse für: de Bruin, Renée C. G.

1

A bispecific nanobody approach to leverage the potent and w..:

de Bruin, Renée C. G. ; Veluchamy, John P. ; Lougheed, Sinéad M....
OncoImmunology. 7 (2017) 1 - p. e1375641 , 2017

Link: https://doi.org/10.1080/..

2

Highly specific and potently activating Vγ9Vδ2-T cell speci..:

de Bruin, Renée C.G. ; Lougheed, Sinéad M. ; van der Kruk, Liza...
Clinical Immunology. 169 (2016) - p. 128-138 , 2016

Link: https://doi.org/10.1016/..

3

Generation and characterization of CD1d‐specific single‐dom..:

Lameris, Roeland ; de Bruin, Renée C. G. ; van Bergen en Henegouwen, Paul M. P....
Immunology. 149 (2016) 1 - p. 111-121 , 2016

Link: https://doi.org/10.1111/..

4

Bispecific antibody platforms for cancer immunotherapy:

Lameris, Roeland ; de Bruin, Renée C.G. ; Schneiders, Famke L....
Critical Reviews in Oncology/Hematology. 92 (2014) 3 - p. 153-165 , 2014

Link: https://doi.org/10.1016/..

5

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effec..:

Schneiders, Famke L. ; de Bruin, Renée C.G. ; Santegoets, Saskia J.A.M....
Clinical Immunology. 142 (2012) 2 - p. 194-200 , 2012

Link: https://doi.org/10.1016/..

6

A biparatopic anti‐EGFR nanobody efficiently inhibits solid..:

Roovers, Rob C. ; Vosjan, Maria J.W.D. ; Laeremans, Toon...
International Journal of Cancer. 129 (2011) 8 - p. 2013-2024 , 2011

Link: https://doi.org/10.1002/..

7

A bispecific nanobody approach to leverage the potent and w..:

de Bruin, Renée C.G ; Veluchamy, John P ; Lougheed, Sinéad M...
de Bruin , R C G , Veluchamy , J P , Lougheed , S M , Schneiders , F L , Lopez-Lastra , S , Lameris , R , Stam , A G , Sebestyen , Z , Kuball , J , Molthoff , C F M , Hooijberg , E , Roovers , R C , Santo , J P D , van Bergen en Henegouwen , P M P , Verheul , H M W , de Gruijl , T D & van der Vliet , H J 2018 , ' A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells ' , OncoImmunology , vol. 7 , no. 1 , e1375641 . https://doi.org/10.1080/2162402X.2017.1375641. , 2018

Link: https://research.vumc.nl..

8

A bispecific nanobody approach to leverage the potent and w..:

de Bruin, Renée C G ; Veluchamy, John P ; Lougheed, Sinéad M...
2162-4011. , 2017

Link: https://dspace.library.u..

9

Correction: Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9..:

de Bruin, Renée C G ; Stam, Anita G M ; Vangone, Anna...
0022-1767. , 2017

Link: https://dspace.library.u..

10

Highly specific and potently activating Vγ9Vδ2-T cell speci..:

de Bruin, Renée C G ; Lougheed, Sinéad M ; van der Kruk, Liza...
1521-6616. , 2016

Link: https://dspace.library.u..

11

Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nano..:

de Bruin, Renée C G ; Stam, Anita G M ; Vangone, Anna...
0022-1767. , 2016

Link: https://dspace.library.u..

12

Generation and characterization of CD1d‐specific single‐dom..:

Lameris, Roeland ; de Bruin, Renée C. G ; van Bergen en Henegouwen, Paul M. P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981610/. , 2016

Link: http://www.ncbi.nlm.nih...

13

Generation and characterization of CD1d-specific single-dom..:

Lameris, Roeland ; de Bruin, Renée C G ; van Bergen en Henegouwen, Paul M P...
0019-2805. , 2016

Link: https://dspace.library.u..

14

A bi-paratopic anti-EGFR nanobody efficiently inhibits soli..:

Roovers, Rob C ; Vosjan, Maria J.W.D ; Laeremans, Toon...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2011

Link: http://www.ncbi.nlm.nih...

15

A bispecific nanobody approach to leverage the potent and w..:

Renée C. G. de Bruin ; John P. Veluchamy ; Sinéad M. Lougheed...
http://dx.doi.org/10.1080/2162402X.2017.1375641. , 2018

Link: https://doi.org/10.1080/..